Article makes simple errors and could cause unnecessary deaths

Comment

Colin Baigent et al. BMJ. 2002.

. 2002 Jan 19;324(7330):167.

doi: 10.1136/bmj.324.7330.167.

No abstract available

Comment in

Chronic aspirin is effective--if data are massaged sufficiently.
Cleland JG. Cleland JG. BMJ. 2002 Feb 2;324(7332):295. BMJ. 2002. PMID: 11823365 Free PMC article. No abstract available.

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
Antithrombotic Trialists' Collaboration. Antithrombotic Trialists' Collaboration. BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71. BMJ. 2002. PMID: 11786451 Free PMC article.

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. BMJ. 2002;324:71–86. . (12 January.) - PMC - PubMed
1. Cleland JGF. For debate: Preventing atherosclerotic events with aspirin. BMJ. 2002;324:103–105. . (12 January.) - PMC - PubMed
1. Cleland JGF. No reduction in cardiovascular risk with NSAIDS—including aspirin? Lancet. 2002;359:92–93. - PubMed
1. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet. 1988;ii:349–360. - PubMed
1. Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R.on behalf of the ISIS-2 Collaborative Group. ISIS-2: 10-year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither BMJ 19983161337–1343. - PMC - PubMed